Ruiz Rivera v. PEIZER PHARMACEUTICALS, LLC

521 F.3d 76, 20 Am. Disabilities Cas. (BNA) 718, 2008 U.S. App. LEXIS 6354, 2008 WL 802730
CourtCourt of Appeals for the First Circuit
DecidedMarch 27, 2008
Docket07-1595
StatusPublished
Cited by344 cases

This text of 521 F.3d 76 (Ruiz Rivera v. PEIZER PHARMACEUTICALS, LLC) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ruiz Rivera v. PEIZER PHARMACEUTICALS, LLC, 521 F.3d 76, 20 Am. Disabilities Cas. (BNA) 718, 2008 U.S. App. LEXIS 6354, 2008 WL 802730 (1st Cir. 2008).

Opinion

SMITH, District Judge.

This case presents as a so-called “regarded as” disability claim under the Americans with Disabilities Act (“ADA”). However, as the discussion below reveals, once the layers of argument are stripped away, the regarded as claim is revealed to be a chimera. Thus, the District Court’s grant of summary judgment, on reconsideration, as to the regarded as claim was appropriate, and the judgment is affirmed.

I. Facts and Background

In late 1997, appellant Delia Ruiz Rivera (“Ruiz Rivera”) began working, on a temporary basis, as a packaging operator in appellee Pfizer Pharmaceutical LLC’s (“Pfizer”) Puerto Rico facility. Nearly one year later, Ruiz Rivera achieved regular employee status when she was assigned to Pfizer’s bottling department. Ruiz Rivera’s position as a packaging operator in the bottling department involved pouring pills, bottles, and caps, monitoring the conveyor, packing and inspecting the product, and cleaning machinery.

*79 Ruiz Rivera became pregnant several months after becoming a regular employee. As her pregnancy progressed, she submitted several notes from her doctor to Pfizer informing it of certain medical-related limitations, including a recommendation that she avoid walking long distances, that her shifts be limited, and that she work only in a seated position.

In August 1999, Ruiz Rivera informed Pfizer of several medical problems, including edema, numbness, and continued effects of a potentially herniated disc. Based on her doctor’s recommendations, Pfizer, through its in-house physician, Dr. Felix, authorized a short leave of absence. Soon after Ruiz Rivera returned from leave, she submitted to Dr. Felix another medical certificate from Dr. Ramos, her physiatrist, asking that she be excused from work from August 30, 1999 through November 1, 1999, citing her herniated disc-related medical problems. Accordingly, Pfizer granted her temporary non-occupational disability leave until November. Come November, Ruiz Rivera sought and was provided another medical leave until January 1, 2000. She gave birth in late December, at which time her eight-week maternity leave commenced.

At the completion of her maternity leave, Ruiz Rivera submitted to Dr. Felix at Pfizer a medical certificate from Dr. Ramos indicating that she was being treated for carpal tunnel syndrome and lumbo sacral disc herniation. Dr. Ramos indicated that Ruiz Rivera was fit to return to work, with specific limitations, recommended that she avoid repetitive hand motions, placing her hands over her shoulders, lifting, pushing, holding, and bending, and placed a twenty-five pound limitation on how much she could lift. At the same time, Ruiz Rivera presented to Dr. Felix a medical certificate from a different doctor diagnosing her with major depression. Based on these two submissions, Pfizer granted an additional month of leave benefits to Ruiz Rivera. On March 27, 2000, after Ruiz Rivera had been on authorized leave for nearly seven straight months, she returned to work and insisted that Pfizer implement her doctor’s earlier recommendations and restrictions. Dr. Felix informed Ruiz Rivera that there were no opportunities available where she could work with such stringent limitations; however, Dr. Felix agreed to confer with Dr. Ramos, and prepared for him a consultation form regarding Ruiz Rivera’s condition, treatment options, and rehabilitation opportunities.

After an additional week of leave, Ruiz Rivera reported back to work at Pfizer. At that time, she provided to Dr. Felix a consultation report which provided, in pertinent part:

Diagnosis

Left Carpal Tunnel Syndrome Both Wrists Tendinitis L(subscript 5)S(subscript l)Discs Herniation
These are progressive diseases and may deteriorate her condition. She uses wrists splints at night and gets anti-inflammatory and muscle relaxants, and needs to protect the affected areas from damage.... She should have some restrictions at her work area, so she can do her job with minimal deterioration of her condition. These restrictions should last at least six months, but may be longer.
-Avoid repetitive motions of hands -Avoid hands-over-the shoulders position -Do not lift over 25 lbs.
-Limit lifting-carrying-pushing-pulling-holding-bending.

Based on the information provided and the restrictions imposed by Dr. Ramos, Dr. Felix concluded that, “[i]n view of this [sic] *80 recommendations and after conversation with [plaintiffs] work area supervisor where she can not perform the essential tasks of her job and needs her hands I do not recommend a RTW [return to work] to prevent further aggravation or lesion. Case discussed [with] HR [Human Resources] for plan of action.”

Ruiz Rivera later spoke to Frances Guzman, Pfizer’s Assistant Personnel Manager, who advised her that Pfizer did not have to accommodate the restrictions imposed by her doctor because, in Guzman’s view, Ruiz Rivera was not disabled under the ADA. 1 Guzman testified at her deposition that she explained to Ruiz Rivera that because she wasn’t entitled to accommodation, she should pursue medical leave and again seek temporary non-occupational disability insurance. Ruiz Rivera asserts that Guzman also told her that because of the conditions imposed by her physicians, there was no opportunity for her to work at Pfizer or at any other pharmaceutical company. While Pfizer took no action to terminate her at this point, Ruiz Rivera did not return to work after these conversations.

Approximately three months later, in a letter dated June 21, 2000, Pfizer requested that Ruiz Rivera return for a meeting to discuss her health and status. Ruiz Rivera responded by letter shortly thereafter, but did not accept Pfizer’s request for a meeting. Approximately six months later, Pfizer again wrote to Ruiz Rivera requesting that she return to work. Ruiz Rivera did not respond. After Ruiz Rivera rebuffed this request, Pfizer officially terminated her employment. 2

The Amended Complaint (the “Complaint”) in this matter alleged numerous violations of federal and Puerto Rico law, including the Americans With Disabilities Act (“ADA”), 42 U.S.C. §§ 12101-12213; the Puerto Rico law counterpart to the ADA, Law No. 44 of July 2, 1985 (“Law 44”); Title VII of the Civil Rights Act, 42 U.S.C. § 2000 et seq.; the Pregnancy Discrimination Act; the Puerto Rico Pregnant Mothers Protection Act (Act No. 3 of March 13, 1942); the Puerto Rico Sex Discrimination in Employment Act (Act No. 69 of July 6, 1985); the Puerto Rico Discrimination in Employment Act (Act No. 100 of June 30, 1959); and Puerto Rico’s Law 80 of May 30, 1976. Through summary judgment, Pfizer moved for dismissal of the Complaint. Soon after, the parties stipulated to dismissal with prejudice of all but the ADA and Law 44 claims.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
521 F.3d 76, 20 Am. Disabilities Cas. (BNA) 718, 2008 U.S. App. LEXIS 6354, 2008 WL 802730, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ruiz-rivera-v-peizer-pharmaceuticals-llc-ca1-2008.